NCT07171216View on ClinicalTrials.gov

The Effect of REgulation of PArathyroId hoRmone in Patients With Chronic Kidney Disease to Investigate the Change in Bone Mineral Density

NANot yet recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

September 1, 2027

Study Completion Date

September 1, 2027

Conditions
Chronic Kidney Disease Mineral and Bone Disorder
Interventions
OTHER

Treat to target

"Participants will receive treatment from a toolbox depending on the situation to reach the PTH target. Available medication is mirroring what is used in the outpatient clinic setting already (native vitamin D, activated vitamin D, phosphate binders, calcimetics)."

Trial Locations (1)

2730

Department of Nephrology, outpatient clinic, Herlev Hospital, Herlev

All Listed Sponsors
lead

Herlev Hospital

OTHER

NCT07171216 - The Effect of REgulation of PArathyroId hoRmone in Patients With Chronic Kidney Disease to Investigate the Change in Bone Mineral Density | Biotech Hunter | Biotech Hunter